List of Tables
Table 1. Global Epidermal Growth Factor Receptor Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Epidermal Growth Factor Receptor Inhibitors Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Epidermal Growth Factor Receptor Inhibitors Market Competitive Situation by Manufacturers in 2023
Table 4. Global Epidermal Growth Factor Receptor Inhibitors Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Epidermal Growth Factor Receptor Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Epidermal Growth Factor Receptor Inhibitors Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Epidermal Growth Factor Receptor Inhibitors Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Epidermal Growth Factor Receptor Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Epidermal Growth Factor Receptor Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Epidermal Growth Factor Receptor Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Epidermal Growth Factor Receptor Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Epidermal Growth Factor Receptor Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epidermal Growth Factor Receptor Inhibitors as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Epidermal Growth Factor Receptor Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Epidermal Growth Factor Receptor Inhibitors Sales by Region (2019-2024) & (K Units)
Table 18. Global Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Region (2019-2024)
Table 19. Global Epidermal Growth Factor Receptor Inhibitors Sales by Region (2025-2030) & (K Units)
Table 20. Global Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Region (2025-2030)
Table 21. Global Epidermal Growth Factor Receptor Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Epidermal Growth Factor Receptor Inhibitors Revenue Market Share by Region (2019-2024)
Table 23. Global Epidermal Growth Factor Receptor Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Epidermal Growth Factor Receptor Inhibitors Revenue Market Share by Region (2025-2030)
Table 25. North America Epidermal Growth Factor Receptor Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Epidermal Growth Factor Receptor Inhibitors Sales by Country (2019-2024) & (K Units)
Table 27. North America Epidermal Growth Factor Receptor Inhibitors Sales by Country (2025-2030) & (K Units)
Table 28. North America Epidermal Growth Factor Receptor Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Epidermal Growth Factor Receptor Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Epidermal Growth Factor Receptor Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Epidermal Growth Factor Receptor Inhibitors Sales by Country (2019-2024) & (K Units)
Table 32. Europe Epidermal Growth Factor Receptor Inhibitors Sales by Country (2025-2030) & (K Units)
Table 33. Europe Epidermal Growth Factor Receptor Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Epidermal Growth Factor Receptor Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Epidermal Growth Factor Receptor Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Epidermal Growth Factor Receptor Inhibitors Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Epidermal Growth Factor Receptor Inhibitors Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Epidermal Growth Factor Receptor Inhibitors Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Epidermal Growth Factor Receptor Inhibitors Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Epidermal Growth Factor Receptor Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Epidermal Growth Factor Receptor Inhibitors Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Epidermal Growth Factor Receptor Inhibitors Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Epidermal Growth Factor Receptor Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Epidermal Growth Factor Receptor Inhibitors Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Epidermal Growth Factor Receptor Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Epidermal Growth Factor Receptor Inhibitors Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Epidermal Growth Factor Receptor Inhibitors Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Epidermal Growth Factor Receptor Inhibitors Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Epidermal Growth Factor Receptor Inhibitors Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Epidermal Growth Factor Receptor Inhibitors Sales (K Units) by Type (2019-2024)
Table 51. Global Epidermal Growth Factor Receptor Inhibitors Sales (K Units) by Type (2025-2030)
Table 52. Global Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Type (2019-2024)
Table 53. Global Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Type (2025-2030)
Table 54. Global Epidermal Growth Factor Receptor Inhibitors Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Epidermal Growth Factor Receptor Inhibitors Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Epidermal Growth Factor Receptor Inhibitors Revenue Market Share by Type (2019-2024)
Table 57. Global Epidermal Growth Factor Receptor Inhibitors Revenue Market Share by Type (2025-2030)
Table 58. Global Epidermal Growth Factor Receptor Inhibitors Price (US$/Unit) by Type (2019-2024)
Table 59. Global Epidermal Growth Factor Receptor Inhibitors Price (US$/Unit) by Type (2025-2030)
Table 60. Global Epidermal Growth Factor Receptor Inhibitors Sales (K Units) by Application (2019-2024)
Table 61. Global Epidermal Growth Factor Receptor Inhibitors Sales (K Units) by Application (2025-2030)
Table 62. Global Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Application (2019-2024)
Table 63. Global Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Application (2025-2030)
Table 64. Global Epidermal Growth Factor Receptor Inhibitors Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Epidermal Growth Factor Receptor Inhibitors Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Epidermal Growth Factor Receptor Inhibitors Revenue Market Share by Application (2019-2024)
Table 67. Global Epidermal Growth Factor Receptor Inhibitors Revenue Market Share by Application (2025-2030)
Table 68. Global Epidermal Growth Factor Receptor Inhibitors Price (US$/Unit) by Application (2019-2024)
Table 69. Global Epidermal Growth Factor Receptor Inhibitors Price (US$/Unit) by Application (2025-2030)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. AstraZeneca Epidermal Growth Factor Receptor Inhibitors Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Roche Epidermal Growth Factor Receptor Inhibitors Product
Table 79. Roche Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Pfizer Epidermal Growth Factor Receptor Inhibitors Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Spectrum Pharmaceuticals Company Information
Table 86. Spectrum Pharmaceuticals Description and Business Overview
Table 87. Spectrum Pharmaceuticals Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Spectrum Pharmaceuticals Epidermal Growth Factor Receptor Inhibitors Product
Table 89. Spectrum Pharmaceuticals Recent Developments/Updates
Table 90. Cullinan Oncology Company Information
Table 91. Cullinan Oncology Description and Business Overview
Table 92. Cullinan Oncology Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Cullinan Oncology Epidermal Growth Factor Receptor Inhibitors Product
Table 94. Cullinan Oncology Recent Developments/Updates
Table 95. Taiho Pharmaceutical Company Information
Table 96. Taiho Pharmaceutical Description and Business Overview
Table 97. Taiho Pharmaceutical Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Taiho Pharmaceutical Epidermal Growth Factor Receptor Inhibitors Product
Table 99. Taiho Pharmaceutical Recent Developments/Updates
Table 100. Lutris Pharma Company Information
Table 101. Lutris Pharma Description and Business Overview
Table 102. Lutris Pharma Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Lutris Pharma Epidermal Growth Factor Receptor Inhibitors Product
Table 104. Lutris Pharma Recent Developments/Updates
Table 105. Boehringer Ingelheim Company Information
Table 106. Boehringer Ingelheim Description and Business Overview
Table 107. Boehringer Ingelheim Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Boehringer Ingelheim Epidermal Growth Factor Receptor Inhibitors Product
Table 109. Boehringer Ingelheim Recent Developments/Updates
Table 110. Puma Biotechnology Company Information
Table 111. Puma Biotechnology Description and Business Overview
Table 112. Puma Biotechnology Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Puma Biotechnology Epidermal Growth Factor Receptor Inhibitors Product
Table 114. Puma Biotechnology Recent Developments/Updates
Table 115. Apollomics Company Information
Table 116. Apollomics Description and Business Overview
Table 117. Apollomics Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Apollomics Epidermal Growth Factor Receptor Inhibitors Product
Table 119. Apollomics Recent Developments/Updates
Table 120. Hutchison MediPharma Company Information
Table 121. Hutchison MediPharma Description and Business Overview
Table 122. Hutchison MediPharma Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Hutchison MediPharma Epidermal Growth Factor Receptor Inhibitors Product
Table 124. Hutchison MediPharma Recent Developments/Updates
Table 125. Johnson & Johnson Services Company Information
Table 126. Johnson & Johnson Services Description and Business Overview
Table 127. Johnson & Johnson Services Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Johnson & Johnson Services Epidermal Growth Factor Receptor Inhibitors Product
Table 129. Johnson & Johnson Services Recent Developments/Updates
Table 130. Daiichi Sankyo Company Information
Table 131. Daiichi Sankyo Description and Business Overview
Table 132. Daiichi Sankyo Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Daiichi Sankyo Epidermal Growth Factor Receptor Inhibitors Product
Table 134. Daiichi Sankyo Recent Developments/Updates
Table 135. Hutchison China MediTech Company Information
Table 136. Hutchison China MediTech Description and Business Overview
Table 137. Hutchison China MediTech Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Hutchison China MediTech Epidermal Growth Factor Receptor Inhibitors Product
Table 139. Hutchison China MediTech Recent Developments/Updates
Table 140. Sihuan Pharmaceutical Company Information
Table 141. Sihuan Pharmaceutical Description and Business Overview
Table 142. Sihuan Pharmaceutical Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Sihuan Pharmaceutical Epidermal Growth Factor Receptor Inhibitors Product
Table 144. Sihuan Pharmaceutical Recent Developments/Updates
Table 145. Astellas Pharma Company Information
Table 146. Astellas Pharma Description and Business Overview
Table 147. Astellas Pharma Epidermal Growth Factor Receptor Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Astellas Pharma Epidermal Growth Factor Receptor Inhibitors Product
Table 149. Astellas Pharma Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Epidermal Growth Factor Receptor Inhibitors Distributors List
Table 153. Epidermal Growth Factor Receptor Inhibitors Customers List
Table 154. Epidermal Growth Factor Receptor Inhibitors Market Trends
Table 155. Epidermal Growth Factor Receptor Inhibitors Market Drivers
Table 156. Epidermal Growth Factor Receptor Inhibitors Market Challenges
Table 157. Epidermal Growth Factor Receptor Inhibitors Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Epidermal Growth Factor Receptor Inhibitors
Figure 2. Global Epidermal Growth Factor Receptor Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Epidermal Growth Factor Receptor Inhibitors Market Share by Type: 2023 & 2030
Figure 4. Cetuximab Product Picture
Figure 5. Erlotinib Product Picture
Figure 6. Gefitinib Product Picture
Figure 7. Other Product Picture
Figure 8. Global Epidermal Growth Factor Receptor Inhibitors Market Value by Application (2024-2030) & (US$ Million)
Figure 9. Global Epidermal Growth Factor Receptor Inhibitors Market Share by Application: 2023 & 2030
Figure 10. Lung Cancer
Figure 11. Liver Cancer
Figure 12. Breast Cancer
Figure 13. Other
Figure 14. Global Epidermal Growth Factor Receptor Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Epidermal Growth Factor Receptor Inhibitors Market Size (2019-2030) & (US$ Million)
Figure 16. Global Epidermal Growth Factor Receptor Inhibitors Sales (2019-2030) & (K Units)
Figure 17. Global Epidermal Growth Factor Receptor Inhibitors Average Price (US$/Unit) & (2019-2030)
Figure 18. Epidermal Growth Factor Receptor Inhibitors Report Years Considered
Figure 19. Epidermal Growth Factor Receptor Inhibitors Sales Share by Manufacturers in 2023
Figure 20. Global Epidermal Growth Factor Receptor Inhibitors Revenue Share by Manufacturers in 2023
Figure 21. Global 5 and 10 Largest Epidermal Growth Factor Receptor Inhibitors Players: Market Share by Revenue in Epidermal Growth Factor Receptor Inhibitors in 2023
Figure 22. Epidermal Growth Factor Receptor Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Global Epidermal Growth Factor Receptor Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Country (2019-2030)
Figure 25. North America Epidermal Growth Factor Receptor Inhibitors Revenue Market Share by Country (2019-2030)
Figure 26. United States Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Country (2019-2030)
Figure 29. Europe Epidermal Growth Factor Receptor Inhibitors Revenue Market Share by Country (2019-2030)
Figure 30. Germany Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Epidermal Growth Factor Receptor Inhibitors Revenue Market Share by Region (2019-2030)
Figure 37. China Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Country (2019-2030)
Figure 45. Mexico Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Epidermal Growth Factor Receptor Inhibitors Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Epidermal Growth Factor Receptor Inhibitors Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Epidermal Growth Factor Receptor Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Epidermal Growth Factor Receptor Inhibitors by Type (2019-2030)
Figure 55. Global Revenue Market Share of Epidermal Growth Factor Receptor Inhibitors by Type (2019-2030)
Figure 56. Global Epidermal Growth Factor Receptor Inhibitors Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Epidermal Growth Factor Receptor Inhibitors by Application (2019-2030)
Figure 58. Global Revenue Market Share of Epidermal Growth Factor Receptor Inhibitors by Application (2019-2030)
Figure 59. Global Epidermal Growth Factor Receptor Inhibitors Price (US$/Unit) by Application (2019-2030)
Figure 60. Epidermal Growth Factor Receptor Inhibitors Value Chain
Figure 61. Epidermal Growth Factor Receptor Inhibitors Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
